Harrington to award University of Massachusetts funding to develop fumarate based therapeutics and multi-virus therapy for lung injury and COVID-19
Harrington Discovery Institute to fund UCSF to develop multi-target antibodies for COVID-19
Innosuisse to award Mymetics and Insel Gruppe funding to conduct preclinical study of the company’s virosome-based COVID-19 nasal vaccine candidate, CoV RBD219-N1